Astec Lifesciences has reported results for the fourth quarter and year ended March 31, 2018.
The company has reported around 5 fold jump in its net profit at Rs 17.10 crore for the quarter ended March 31, 2018 as compared to Rs 3.49 crore for the same quarter in the previous year. Total income of the company has increased by 42.56% at Rs 130.14 crore for quarter under review as compared to Rs 91.29 crore for the quarter ended March 31, 2017.
On consolidated basis, the company has reported around 5 fold jump in its net profit at Rs 17.16 crore for the quarter ended March 31, 2018 as compared to Rs 3.46 crore for the corresponding quarter in the FY17. Total consolidated income of the company rose 42.48% at Rs 130.14 crore for quarter under review as compared to Rs 91.34 crore for the same quarter ended previous year.
For the year ended March 31, 2018, the company has posted a rise of 83.18% in its net profit at Rs 34.97 crore as compared to Rs 19.09 crore for the same period in the previous year. Total income of the company increased 20.07% at Rs 378.95 crore for year under review as compared to Rs 315.60 crore for the period ended March 31, 2017.
For the year ended March 31, 2018, on the consolidated basis, the company has posted a rise of 82.53% in its net profit at Rs 34.90 crore as compared to Rs 19.12 crore for the same period in the previous year. Total income of the company has increased by 19.82% at Rs 378.95 crore for year under review as compared to Rs 316.27 crore for the period ended March 31, 2017.
